A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension

Abstract

The aetiology of essential hypertension, a disease prevalent in cultured societies, is unknown. However, much evidence suggests that abnormal sodium metabolism has a critical role—this has led to the hypothesis that an increase in the circulating concentration of an inhibitor of (Na+ + K+) ATPase is responsible for the increased peripheral vascular resistance in essential hypertension1. Evidence for relatively high levels of a Na+ pump inhibitor in essential hypertension has come from bioassay and cytochemical assays of plasma and urine from normotensive and hypertensive individuals2,3. There is also evidence for increased plasma levels of a Na+ pump inhibitor in some animal models (for example, renal and deoxycorticosterone acetate (DOCA) models) of hypertension4. Nevertheless, direct biochemical determination of (Na+ + K+) ATPase inhibition by this substance has not yet been reported. We demonstrate here, with a kinetic (Na+ + K+) ATPase assay, a highly significant correlation between levels of a plasma inhibitor of (Na+ + K+)ATPase activity and mean arterial blood pressure (MAP) in normotensive and hypertensive individuals. These data provide evidence for the involvement of a circulating Na+ pump inhibitor in the genesis of essential hypertension. Moreover, our assay methods may be useful for the isolation and characterization of this inhibitor.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Blaustein, M. P. Am. J. Physiol. 232, C165–C173 (1977).

  2. 2

    MacGregor, G. A. et al. Br. med. J. 283, 1335–1357 (1981).

  3. 3

    Poston, L. et al. Br. med. J. 282, 847–849 (1981).

  4. 4

    Pamnani, M. B., Huot, S., Buggy, J., Clough, D. & Haddy, F. Hypertension 3, Suppl. Ii, II-96–Ii-101 (1981).

  5. 5

    Akera, T., Choi, Y. R. & Yamamoto, S. in Na, K-ATPase, Structure and Kinetics (eds Skou, J. C. & Norby, J. G.) 405–420 (Academic, New York, 1979).

  6. 6

    Fagan, J. B. & Racker, E. Biochemistry 16, 152–158 (1977).

  7. 7

    Quist, E. E. & Hokin, L. E. Biochim. biophys. Acta 511, 202–212 (1978).

  8. 8

    Cantley, L. C. et al. J. biol Chem. 252, 7421–7423 (1977).

  9. 9

    Jorgensen, P. L. Biochim. biophys. Acta 356, 36–52 (1974).

  10. 10

    Gruber, K. A., Whitaker, J. M. & Buckalew, V. M. Nature 287, 743–745 (1980).

  11. 11

    Gruber, K. A., Rudel, L. L. & Bullock, B. C. Hypertension 4, 348–354 (1982).

  12. 12

    Losse, H., Wehmeyer, H. & Wessels, F. Klin. Wschr. 38, 393–395 (1960).

  13. 13

    Edmondson, R. P. S., Thomas, R. D., Hilton, P. J., Patrick, J. & Jones, N. F. Lancet i, 1003–1005 (1975).

  14. 14

    Blaustein, M. P. Clin. exp. Hypertension 3, 173–178 (1981).

  15. 15

    Blaustein, M. P. in Recent Advances in Hypertension Mechanisms (eds Villareal, H. & Sambhi, M.) (in the press).

  16. 16

    Lang, S. & Blaustein, M. P. Circulation Res. 46, 463–470 (1980).

  17. 17

    Filo, R. S., Bohr, D. F. & Rüegg, J. C. Science 147, 1581–1583 (1972).

  18. 18

    Folkow, B. & Neil, E. Circulation, 560–583 (Oxford University Press, 1971).

  19. 19

    Nakazato, Y., Ohga, A. & Onoda, Y. J. Physiol., Land. 278, 45–54 (1978).

  20. 20

    Leitz, F. H. & Stefano, F. J. E. Eur. J. Pharmac. 11, 278–285 (1970).

  21. 21

    de Wardener, H. E. & MacGregor, G. A. Kidney Int. 18, 1–9 (1980).

  22. 22

    de Wardener, H. E. Am. J. Physiol. 235, F163–F173 (1978).

  23. 23

    Zadik, Z., Hamilton, B. P. & Kowarski, A. A. J. clin Endocr. Metab. 50, 842–845 (1980).

  24. 24

    Kowarski, A. A., Edwin, C. J., Akesode, A. P., Pitrowski, L. S. & Hamilton, B. P. Johns Hopkins med. J. 142, 35–38 (1978).

  25. 25

    King, E. J. Biochem. J. 26, 292–297 (1932).

  26. 26

    Bradford, M. M. Analyt. Biochem. 72, 248–254 (1976).

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hamlyn, J., Ringel, R., Schaeffer, J. et al. A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension. Nature 300, 650–652 (1982). https://doi.org/10.1038/300650a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.